Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in mice. [electronic resource]
- Virus research Aug 2012
- 236-46 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't